Concurrent hyperbaric oxygen therapy and intratympanic steroid application as salvage therapy after severe sudden sensorineural hearing loss

  • Clin Case Rep. 2016 Feb 11;4(3):287-93. doi: 10.1002/ccr3.510.
Hans Lamm  1 ,  Claus Müller-Kortkamp  2 ,  Athanasia Warnecke  3 ,  Friederike Pohl  1 ,  Gerrit Paasche  3 ,  Thomas Lenarz  3 ,  Stefan R O Stolle  1
Affiliations
  • 1. Department of Otorhinolaryngology Hannover Medical School Carl-Neuberg-Str. 1 Hannover 30625 Germany.
  • 2. Private Practice for Otorhinolaryngology Institute of Hyperbaric Medicine Seilerstr. 7-9 Hannover 29614 Germany.
  • 3. Department of Otorhinolaryngology Hannover Medical School Carl-Neuberg-Str. 1 Hannover 30625 Germany; Hearing 4 all Cluster of Excellence Hannover Germany.
PMID: 27014454 DOI: 10.1002/ccr3.510
Abstract

Concurrent hyperbaric oxygen therapy (HBOT) and intratympanic steroid application (ITS) are beneficial as salvage therapy for therapy-refractory sudden sensorineural hearing loss (SSNHL). The findings encourage further research on the treatment of noise-induced and idiopathic SSNHL with concurrent use of HBOT and ITS respecting also patients with long-term or therapy-refractory SSNHL.

Keywords
Concurrent hyperbaric oxygen therapy; intratympanic steroid application; sudden deafness; sudden sensorineural hearing loss.